ASX:CSL
ASX:CSLBiotechs

CSL (ASX:CSL) Valuation Check After Robust Five-Year HEMGENIX Gene Therapy Results

CSL (ASX:CSL) has sparked fresh interest after unveiling five year HOPE B trial results for its gene therapy HEMGENIX, showing sustained efficacy and safety that could reshape reimbursement debates, especially in Australia. See our latest analysis for CSL. Yet despite a string of positives, from the new Melbourne vaccine facility to the ongoing buy-back and now the standout HEMGENIX data, CSL’s 1 year total shareholder return of around minus 34 percent and steep year to date share price...
ASX:TLX
ASX:TLXBiotechs

Does Telix (ASX:TLX) And Varian’s PSMA-PET Tie-Up Redefine Its Radiotherapy Moat?

Telix Pharmaceuticals recently announced a clinical collaboration with Varian, a Siemens Healthineers company, to combine its theranostic radiopharmaceuticals with external beam radiation therapy, initially focusing on PSMA-PET imaging in prostate cancer. This tie-up could broaden the role of nuclear medicine in radiation oncology by using Telix’s Gozellix and Illuccix to sharpen patient selection and treatment planning. Next, we’ll examine how this Varian collaboration around...
ASX:RMS
ASX:RMSMetals and Mining

Ramelius Resources (ASX:RMS) Is Up 7.3% After Announcing A$250m Buyback And Higher Dividend - What's Changed

Ramelius Resources has launched a A$250 million share buyback program, approved on 10 December 2025, to repurchase up to 73,964,497 shares (3.84% of its 1,924,864,769 issued shares) by June 2027 as a way of returning capital to investors. Alongside the buyback, Ramelius has lifted its minimum annual dividend to 2 cents per share and outlined a 5‑year growth plan targeting higher gold production, signalling confidence in cash generation and business expansion plans. We’ll now examine how...
ASX:BWP
ASX:BWPRetail REITs

BWP Trust (ASX:BWP): Valuation Check After Upgraded Half-Year Distribution Guidance

BWP Trust (ASX:BWP) has just guided to a higher half year payout, flagging a preliminary distribution of 9.58 cents per stapled security, up about 4% on the prior period. See our latest analysis for BWP Trust. The upbeat distribution guidance has landed against a supportive backdrop, with the share price at A$3.93 and an 18.73% year to date share price return pointing to rebuilding momentum, while the 1 year total shareholder return of 24.92% underlines how income plus modest growth has...
ASX:DXB
ASX:DXBBiotechs

ASX Penny Stocks To Consider In December 2025

As the Australian market shows signs of a potential rally to close out the year, investors are eyeing opportunities that extend beyond the major indices. Penny stocks, often associated with smaller or newer companies, continue to attract attention for their potential growth and value propositions. Despite being considered an outdated term by some, these stocks remain relevant as they can offer unique opportunities for those looking to explore under-the-radar investments with strong financial...
ASX:RGN
ASX:RGNRetail REITs

Does Region Group’s Ongoing Buy-back Clarify Its Capital Priorities for Investors (ASX:RGN)?

Region Group recently continued its on‑market buy-back of stapled securities, repurchasing more than 8.8 million units, including hundreds of thousands in the latest trading sessions, as part of its capital management efforts. This ongoing buy-back reduces the pool of outstanding securities, which can incrementally increase each remaining holder’s ownership share and influence future per‑security metrics. We’ll now explore how Region Group’s active on‑market buy-back program may affect its...
ASX:RWC
ASX:RWCBuilding

Does Reliance Worldwide’s (ASX:RWC) Pay Revolt Reveal Deeper Questions About Management Alignment?

In recent weeks, Reliance Worldwide’s AGM outcomes have drawn attention as nearly 2 million performance rights lapsed, shareholders delivered a second strike against the remuneration report, and the CEO received a new long-term equity incentive grant. This combination of unmet performance hurdles and visible shareholder pushback on pay has intensified scrutiny of the company’s governance and management alignment with investors. We’ll now examine how this governance tension, especially the...
ASX:ARG
ASX:ARGCapital Markets

Does Argo’s 5% Share Buyback Plan (ASX:ARG) Reshape Its Capital Allocation Narrative?

Argo Investments Limited (ASX:ARG) recently announced a share buyback program authorizing the repurchase of up to 35,018,817 shares, or 5% of its 760,112,620 shares on issue, for capital management purposes through to December 31, 2025. This board-approved capital management move is important because it can reduce the share count over time and signals confidence in the company’s balance sheet strength. We’ll now explore how Argo’s decision to repurchase up to 5% of its shares shapes the...
ASX:BAP
ASX:BAPRetail Distributors

Bapcor (ASX:BAP) Is Down 22.3% After Cutting FY26 Guidance And Flagging First-Half Loss

Bapcor Limited has downgraded its FY26 profit guidance and warned of a statutory net loss of A$5,000,000 to A$8,000,000 for the first half, driven by underperformance in its core Trade division, weaker tools and equipment revenue, and one-off restructuring costs. Analysts and investors are increasingly concerned that repeated downgrades, leadership changes such as the recent resignation of Lead Independent Director Mark Powell, and pressure on lending covenants point to a more difficult and...
ASX:TPG
ASX:TPGTelecom

The Bull Case For TPG Telecom (ASX:TPG) Could Change Following Triple Zero Outages And Capital Raise

In recent months, TPG Telecom has faced intense regulatory scrutiny and a Senate inquiry in Australia after multiple Triple Zero (000) emergency call failures involving outdated Samsung devices on its network, with the company working with authorities to investigate possible links to customer deaths and urging tens of thousands of affected users to update their software or replace handsets. At the same time, TPG completed a retail reinvestment plan that raised A$73.40 million to repay bank...
ASX:NAB
ASX:NABBanks

NAB (ASX:NAB) Valuation Check as New $60b Affordable Housing Push Takes Shape

National Australia Bank (ASX:NAB) has turned heads with a new strategic push into affordable housing, committing construction finance for three Assemble projects worth about $500 million as part of a broader $60 billion housing financing ambition by 2030. See our latest analysis for National Australia Bank. That affordable housing push comes after a steady run for the bank, with the latest A$41.38 share price sitting on an 11.12 percent year to date share price return and a powerful 121.39...
ASX:SHA
ASX:SHAConstruction

3 ASX Stocks That May Be Trading Up To 49.1% Below Intrinsic Value Estimates

The Australian stock market has faced challenges this year, with the ASX200 underperforming compared to a basket of its peers despite some sectors like materials and real estate showing resilience. In such an environment, identifying undervalued stocks can be crucial for investors seeking potential opportunities, as these stocks may offer value relative to their intrinsic worth amidst broader market fluctuations.